Use of a subcutaneous implantable pleural port in the management of recurrent malignant pleurisy: Five-year experience based on 168 subcutaneous implantable pleural ports

Journal of Palliative Medicine

Volumn 14, Issue 7, 2011, Pages 829-834

  Kriegel, Irène ^a   Daniel, Catherine ^a   Falcou, Marie Christine ^a   Marcou, Aurore ^a   De Bosschère, Lucile ^a   Benarab, Smina ^a   Livartowski, Alain ^a   Estève, Marc ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CATHETER; CELLULITIS; CLINICAL ASSESSMENT; DYSPNEA; FEMALE; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PLEURA EMPYEMA; PLEURISY; PLEURODESIS; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT MALIGNANT PLEURISY; SUBCUTANEOUS IMPLANTABLE PLEURAL PORT; SURVIVAL TIME; THORACOCENTESIS; THORACOSCOPY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETERS, INDWELLING; DRAINAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION, MALIGNANT; PLEURISY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79959711323     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2010.0539     Document Type: Article

References (28)

1. Antunes G, Neville E, Duffy J, Ali N, on behalf of the BTS Pleural Disease Group, a subgroup of the BTS Standards of Care Committee. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58:29-38.
2. Spector M, Pollak JS. Management of malignant pleural effusions. Semin Respir Crit Care Med 2008;29:405-413.
3. Haas AR, Sterman DH, Musani AI. Malignant pleural effusions. management options with consideration of coding, billing, and a decision approach. Chest 2007;132:1036-1041.
4. Heffner JE, Klein JS. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc 2008;83:235-250. [Erratum in. Mayo Clin Proc 2009;84:847.] (Pubitemid 351303104)
5. Neragi-Miandoab S. Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology. Support Care Cancer 2008;16:1323-1331.
6. Khaleeq G, Musani AI. Emerging paradigms in the management of malignant pleural effusions. Respir Med 2008; 102:939-948.
7. Bazerbashi S, Villaquiran J, Awan MY, Unsworth-White MJ, Rahamim J, Marchbank A. Ambulatory intercostal drainage for the management of malignant pleural effusion. A single center experience. Ann Surg Oncol 2009;16:3482-3487.
8. Monsky WL, Yoneda KY, MacMillan J, Deutsch LS, Dong P, Hourigan H, Schwartz Y, Magee S, Duffield C, Boak T, Cernilia J. Peritoneal and pleural ports for management of refractory ascites and pleural effusions. Assessment of impact on patient quality of life and hospice/home nursing care. J Palliat Med 2009;12:811-817.
9. Daniel C, Kriegel I, Di Maria S, Patrubani G, Levesque R, Livartowski A, Esteve M. Use of a pleural implantable access system for the management of malignant pleural effusion. The Institut Curie experience. Ann Thorac Surg 2007;84. 1367-1370. (Pubitemid 47417854)
10. Hsu LH, Soong TC, Feng AC, Liu MC. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J Thorac Oncol 2006;1:460-467. (Pubitemid 47181424)
11. Boland GW, Gazelle GS, Girard MJ, Mueller PR. Asymptomatic hydropneumothorax after therapeutic thoracentesis for malignant pleural effusions. AJR Am J Roentgenol 1998;170:943-946. (Pubitemid 28172878)
12. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion. British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010;65(Suppl 2):ii32-ii40.
13. Yoneda KY, Mathur PN, Gasparini S. The evolving role of interventional pulmonary in the interdisciplinary approach to the staging and management of lung cancer. Part III. Diagnosis and management of malignant pleural effusions [review]. Clin Lung Cancer 2007;8:535-547. (Pubitemid 350292227)
14. Lombardi G, Zustovich F, Nicoletto MO, Donach M, Artioli G, Pastorelli D. Diagnosis and treatment of malignant pleural effusion. A systematic literature review and new approaches. Am J Clin Oncol 2009; 33:420-423.
15. Musani A I, Haas AR, Seijo L, Wilby M, Sterman DH. Outpatient management of malignant pleural effusions with smallbore, tunneled pleural catheters. Respiration 2004;71:559-566. (Pubitemid 40091427)
16. Van Den Toorn LM, Schaap E, Surmont VFM, Pouw EM, Van der Rijt KCD, Van Klaveren RJ. Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer 2005;50:127-127.
17. Putnam JB, Walsh GL, Swisher SG, Roth JA, Suell DM, Vaporciyan AA, Smythe WR, Merriman KW, Deford LL. outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000; 69:369-375. (Pubitemid 30125561)
18. Putnam JB, Light RW, Rodriguez RM, Ponn R, Olak J, Pollak JS, Lee RB, Payne DK, Graeber G, Kovitz KL. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-1999.
19. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-368. (Pubitemid 43289856)
20. Warren WH, Kalimi R, Khodadadian LM, Kim AW. Management of malignant pleural effusions using the Pleur(x) catheter. Ann Thorac Surg 2008;85:1049-1055. (Pubitemid 351253535)
21. Cases E, Seijo L, Disdier C, Lorenzo MJ, Cordovilla R, Sanchis F, Lacunza M, Sevillano G, Benito-Send?́n F. [Use of indwelling pleural catheter in the outpatient management of recurrent malignant pleural effusion]. Arch Broncopneumol 2009;45:591-596.
22. Murthy SC, Okereke I, Mason DP, Rice TW. A simple solution for complicated pleural effusions. J Thorac Oncol 2006;1:697-700. (Pubitemid 47163959)
23. Burgers JA, Olijve A, Baas P. [Chronic indwelling pleural catheter for malignant pleural effusion in 25 patients]. Ned Tijdschr Geneeskd 2006;150:1618-1623. (Pubitemid 44139590)
24. Sioris T, Sihvo E, Salo J, Räsänen J, Knuuttila A. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis. Eur J Surg Oncol 2009;35:546-551.
25. Mahmood K, Bower C. Treatment of infection associated with tunnelled pleural catheters. J Bronchol Intervent Pulmonol 2010;17:69-72.
26. Warren WH, Kim AW, Liptay MJ. Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion. Eur J Cardiothorac Surg 2008;33:89-94. (Pubitemid 350266354)
27. Aelony Y. Talc pleurodesis and acute respiratory distress syndrome. Lancet 2007;370:387; author reply 387.
28. Qureshi RA, Collinson SL, Powell RJ, Froeschle PO, Berrisford RG. Management of malignant pleural effusion associated with trapped lung syndrome. Asian Cardiovasc Thorac Ann 2008;16:120-123. (Pubitemid 351649798)